Publication: Recrudescence in artesunate-treated patients with falciparum malaria is dependent on parasite burden not on parasite factors
1
Issued Date
2003-02-01
Resource Type
ISSN
00029637
Other identifier(s)
2-s2.0-0037313684
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
American Journal of Tropical Medicine and Hygiene. Vol.68, No.2 (2003), 147-152
Suggested Citation
Wanida Ittarat, Amy L. Pickard, Panthip Rattanasinganchan, Polrat Wilairatana, Sornchai Looareesuwan, Kathryn Emery, Jonathan Low, Rachanee Udomsangpetch, Steven R. Meshnick Recrudescence in artesunate-treated patients with falciparum malaria is dependent on parasite burden not on parasite factors. American Journal of Tropical Medicine and Hygiene. Vol.68, No.2 (2003), 147-152. Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/20931
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Recrudescence in artesunate-treated patients with falciparum malaria is dependent on parasite burden not on parasite factors
Abstract
Artemisinin derivatives are first-line antimalarial drugs in Thailand. No firm evidence of clinically relevant artemisinin resistance exists. When used as monotherapy, artesunate has been associated with a high treatment failure (recrudescence) rate, which could be due to low-level artemisinin resistance. To understand the causes of recrudescence, we retrospectively studied a cohort of 104 malaria patients treated with artesunate monotherapy, 32 of whom recrudesced. There was no difference in in vitro artesunate sensitivities between 6 nonrecrudescent isolates and 16 paired admission and recrudescent isolates. Paired admission and recrudescent isolates from 10 patients were genotyped; only 3 had pfmdr1 mutations. Patients with admission parasitemias >10,000 per μl had a 9-fold higher likelihood of recrudescence (adjusted odds ratio) compared with patients with lower parasitemias. This study suggests (1) recrudescence after treatment with artesunate is not the result of inherent parasite resistance, and (2) admission parasitemia may be useful in choosing therapeutic options.